Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Pegvisomant: an advance in clinical efficacy in acromegaly
Paul Stewart
Medical and Dental Sciences
Research output
:
Contribution to journal
›
Review article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pegvisomant: an advance in clinical efficacy in acromegaly'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
pegvisomant
100%
Acromegaly
74%
Insulin-Like Growth Factor I
60%
Growth Hormone
34%
Somatotropin Receptors
33%
Tachyphylaxis
16%
Hormone Antagonists
16%
Sweating
14%
Premature Mortality
14%
Paresthesia
13%
Dimerization
13%
Dopamine Agonists
13%
Pituitary Neoplasms
13%
Sleep Apnea Syndromes
13%
Arthralgia
12%
Subcutaneous Injections
12%
Somatostatin
12%
Headache
10%
Fatigue
10%
Diabetes Mellitus
9%
Reference Values
9%
Comorbidity
9%
Therapeutics
7%
Hypertension
7%
Safety
7%
Survival
6%
Serum
5%
Population
4%